<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03035825</url>
  </required_header>
  <id_info>
    <org_study_id>DIF-05</org_study_id>
    <nct_id>NCT03035825</nct_id>
  </id_info>
  <brief_title>Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients</brief_title>
  <official_title>A Randomized Controlled Trial for Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients With Xerostomia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dental Innovation Foundation Under Royal Patronage</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Srinakharinwirot University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dental Innovation Foundation Under Royal Patronage</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized control trial aims to investigate the efficacy of oral moisturizing jelly in
      head and neck cancer patients with xerostomia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oral moisturizing jelly is a novel edible, gel-based artificial saliva. It has been proven
      effective in reducing dry mouth sign and symptoms in elderly patients with xerostomia. This
      randomized control trial intends to determine if continuous use of oral moisturizing jelly
      may be effective in reduction of signs and symptoms of dry mouth, improvement of biochemical
      properties of saliva, subjective swallow ability, appetite, tolerance to spicy food, energy
      intake and reduce umami taste recognition threshold.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in subjective dry mouth score compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of subjective dry mouth score by questionaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in objective dry mouth score compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of objective dry mouth score by oral examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in salivary pH compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of salivary pH using pH indicator paper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in salivary buffering capacity compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of salivary buffering capacity using a commercial saliva check buffer kit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Candidal counts of saliva compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of number of fungal colonies of Candida spp. in saliva by culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in energy intake compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of energy intake per day using dietary record and analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in subjective swallow ability compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of subjective swallow ability using EAT-10 questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in appetite compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of appetite using questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in tolerance to spicy food</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of tolerance to spicy food using questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in umami taste recognition threshold compared to baseline</measure>
    <time_frame>Baseline, 1 and 2 months after intervention</time_frame>
    <description>Evaluation of umami taste recognition threshold using filter paper disc method</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Cancer of Head Neck</condition>
  <condition>Radiation-Induced Xerostomia</condition>
  <condition>Dry Mouth</condition>
  <arm_group>
    <arm_group_label>Oral Moisturizing Jelly</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily intake of oral moisturizing jelly 5 times/day for two months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Artificial saliva</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily use of non-edible oral lubricating gel 5 times/day for two months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral moisturizing jelly</intervention_name>
    <description>Gel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth</description>
    <arm_group_label>Oral Moisturizing Jelly</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Artificial saliva</intervention_name>
    <description>A non-edible oral lubricating gel for dry mouth patients</description>
    <arm_group_label>Artificial saliva</arm_group_label>
    <other_name>Dry mouth gel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Xerostomic head and neck cancer patients who finish radiotherapy for at least 1 month.

          2. If undergoing chemotherapy, have to finish for at least 2 weeks.

          3. Have subjective dry mouth scores at least 3

          4. Can perform oral intake without aspiration

          5. Can communicate well

        Exclusion Criteria:

          1. Has recurrence of cancer

          2. Has mucositis more than grade 1

          3. Has oral infection such as candidiasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aroonwan Lam-ubol, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Srinakarinwirot University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aroonwan Lam-ubol, DDS, PhD</last_name>
    <phone>6681-9363145</phone>
    <email>aroonwanlam@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dunyaporn Trachootham, DDS, PhD</last_name>
    <email>dif.dunyaporn@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chonburi Cancer Hospital</name>
      <address>
        <city>Chonburi</city>
        <zip>20000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Onong Mungkung, DDS</last_name>
      <email>o.mungkung@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>January 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2017</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

